RxCentric

About RxCentric

Founded in 1999 and headquartered in New York, RxCentric developed online marketing solutions tailored for pharmaceutical companies. The company's core business was providing software that enabled pharmaceutical clients to customize and target their online marketing efforts, with a particular focus on reaching physicians. This platform offered medical professionals quick access to extensive drug information from trusted sources, aiming to be a key resource in their clinical practice.

The business model centered on creating a digital bridge between drug manufacturers and healthcare providers. By offering valuable, easily accessible information to physicians, RxCentric created a focused audience that was attractive to pharmaceutical marketers. This approach allowed their clients to more effectively communicate product benefits and updates. The company operated within the healthcare practice management and digital marketing sectors.

RxCentric successfully navigated multiple funding rounds, securing significant investment to fuel its growth. In April 2000, it raised $14 million in a Series B round from investors including CHL Medical Partners and MSD Capital. This was followed by a $5 million Series C round in July 2001, with participation from previous investors like Insight Capital Partners and CHL Medical Partners, bringing its total raised capital to $21 million at that time. Over its history, the company raised a total of $24.5M. A notable milestone was its acquisition of DNA Healthcare in July 2000. The company's trajectory culminated in its acquisition by Veradigm on July 16, 2003.